Why is the gold standard not so bright anymore? The rising prevalence of mycoses over the past 20 years has led to the development of more advanced technologies to study fungal pathogenesis. However, up to date research in laboratory settings still greatly relies on conventional methods such as histological examinations, microbiological cultures, and enumeration of colony forming units. In preclinical settings, these ex vivo approaches lack in providing information on the dynamics of the infection in time and space and do not account for interindividual variation of the disease progression [1, 2]. In addition, these experimental gold standards are endpoint assays where fungal load is analyzed postmortem, resulting in only one time point per animal, thus requiring large groups of animals. Preclinical noninvasive imaging techniques are increasingly used in research because they have the potential to deliver dynamic information on individual animals on a relevant time scale. Moreover, multimodal imaging (i.e., the combination of different imaging techniques and imaging scales) could provide us the complementary information to fully investigate fungal disease progression, host responses, and therapeutic efficacy [3]. This Review highlights the potential of using advanced noninvasive imaging techniques to address biological questions within the field of pathogenic fungi.